De Pover A, Godfraind T
Naunyn Schmiedebergs Arch Pharmacol. 1982 Nov;321(2):135-9. doi: 10.1007/BF00518481.
The inhibitory effect of formylated cardiac steroids (gitaloxin and its derivatives) on guinea-pig heart Na, K-ATPase was compared to that of other cardiac steroids with various hydroxy substituents. The decreasing order of potency of aglycones at equilibrium was as follows: gitaloxigenin greater than digitoxigenin greater than ouabagenin greater than digoxigenin greater than gitoxigenin greater than diginatigenin. This sequence was different to the sequence of drugs hydrophobic character. The compounds with hydroxy groups in the vicinity of the lactone ring (gitoxigenin, diginatigenin) were less potent than the hydrophilic compound ouabagenin. We propose that intramolecular bounding between 16 beta-OH and the lactone ring contributes to the relatively low potency of gitoxigenin and diginatigenin. The formylation of 16 beta-OH increased the potency of gitoxigenin by a factor of 41. The formylated compound (gitaloxigenin) was 5-fold more potent than digitoxigenin. The 3 beta-glycosylation of digoxigenin lead to pseudo-irreversible inhibitors of Na, K-ATPase. The half-time to achieve the equilibrium (for 5 mumol/l) was equal to 54 s, 90 s and 108 s respectively for digoxigenin monodigitoxoside, digoxin and desacetyllanatoside C. However, at equilibrium the three glycosides were equipotent, suggesting the existence of steric effects at the sugar site of the receptor. The sequence of potency observed for monodigitoxosides, monodigitalosides and tridigitoxosides after 60 min incubation was similar to that observed for the corresponding aglycones. These results suggest that the strongly negative inductive group 16 beta-OCHO is tightly bound to Na, K-ATPase, possibly to the same receptor site than that which is thought forming hydrogen and ionic bonds with the lactone ring. They show that the high toxicity of gitaloxin in guinea-pig heart is likely due to its high potency as Na, K-ATPase inhibitor.
将甲酰化强心甾类化合物(吉他洛辛及其衍生物)对豚鼠心脏钠钾 - ATP酶的抑制作用与其他具有不同羟基取代基的强心甾类化合物进行了比较。苷元在平衡时效力的递减顺序如下:吉他洛苷元>洋地黄毒苷元>哇巴因苷元>地高辛苷元>吉托苷元>双羟基洋地黄毒苷元。该顺序与药物疏水特性的顺序不同。在内酯环附近带有羟基的化合物(吉托苷元、双羟基洋地黄毒苷元)的效力低于亲水性化合物哇巴因苷元。我们提出16β - OH与内酯环之间的分子内结合导致吉托苷元和双羟基洋地黄毒苷元的效力相对较低。16β - OH的甲酰化使吉托苷元的效力提高了41倍。甲酰化化合物(吉他洛苷元)的效力比洋地黄毒苷元高5倍。地高辛苷元的3β - 糖基化产生了钠钾 - ATP酶的假不可逆抑制剂。对于地高辛单洋地黄毒糖苷、地高辛和去乙酰毛花苷C,达到平衡(5 μmol/L)的半衰期分别为54秒﹑90秒和108秒。然而,在平衡时这三种糖苷具有同等效力,表明在受体的糖位点存在空间效应。孵育60分钟后,单洋地黄毒糖苷、单地高糖苷和三地高糖苷观察到的效力顺序与相应苷元观察到的顺序相似。这些结果表明,强吸电子基团16β - OCHO与钠钾 - ATP酶紧密结合,可能与被认为与内酯环形成氢键和离子键的同一受体位点结合。它们表明吉他洛辛在豚鼠心脏中的高毒性可能归因于其作为钠钾 - ATP酶抑制剂的高效力。